Jill’s Story: Advocating for Patients with Acromegaly
March 6, 2024
Jill Sisco isn’t just an advocate – she’s also a patient herself. She’s been living with Acromegaly, a rare disease that causes an overproduction of growth hormones, since 2005. In our latest video, Jill talks about all the ways Anovo has helped those in her community remove the burden of living with a rare disease, from stopping medication delays before they happen to reducing anxiety around communicating with physicians.
“Anovo is a company that always does the right thing for patients.”
Related Posts
![Cycle Pharmaceuticals and Anovo Deliver Relief to Those with Homozygous Cystinuria](https://anovorx.com/wp-content/uploads/2024/07/ANOVO-0077-Cycle-Pharma-Partnership-v2.1.jpg)
Cycle Pharmaceuticals and Anovo Deliver Relief to Those with Homozygous Cystinuria
Cycle Pharmaceuticals was founded in 2012 with one mission in mind: delivering best-in-class drug treatments and services to the underserved…
July 29, 2024
![Advancing Rare Disease Care: Insights from the World Orphan Drug Congress and AAN Annual Meeting](https://anovorx.com/wp-content/uploads/2024/06/ANOVO-0086-Q2-WODC-ANN-Logos-v1.1.jpg)
Advancing Rare Disease Care: Insights from the World Orphan Drug Congress and AAN Annual Meeting
The World Orphan Drug Congress (WODC) and the American Academy of Neurology (AAN) Annual Meeting are where healthcare leaders, advocates,…
June 11, 2024
![Pyros and Anovo Partner to Elevate Care for Infantile Spasms](https://anovorx.com/wp-content/uploads/2024/04/Partnership-Post-Pyros-Pharmaceuticals.jpeg)
Pyros and Anovo Partner to Elevate Care for Infantile Spasms
Pyros Pharmaceuticals works to elevate the standard of care for children with rare disease by pioneering treatment options like VIGPODER™…
April 1, 2024